Related Experiment Video

Updated: May 22, 2026

Assessment of the Metabolic Profile of Primary Leukemia Cells
06:21

Assessment of the Metabolic Profile of Primary Leukemia Cells

Published on: November 21, 2018

Cancer cell metabolism: there is no ROS for the weary

Chi V Dang1

  • 1Abramson Cancer Center, Abramson Family Cancer Research Institute, Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19072, USA. dangvchi@upenn.edu

Cancer Discovery
|May 12, 2012
PubMed

Insights

Researchers found that blocking 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 (PFKFB4) is crucial for prostate cancer cell survival. Inhibiting this glycolytic enzyme induces cancer cell death, highlighting PFKFB4 as a potential therapeutic target.

Area of Science:

  • Biochemistry
  • Oncology
  • Molecular Biology

Background:

  • Prostate cancer survival relies on specific metabolic pathways.
  • Identifying critical metabolic nodes is key for targeted cancer therapies.

Purpose of the Study:

  • To identify key metabolic regulators essential for prostate cancer cell viability.
  • To explore the therapeutic potential of targeting identified metabolic nodes.

Main Methods:

  • Conducted a high-throughput short-hairpin RNA library screen.
  • Targeted 222 distinct metabolic nodes.
  • Analyzed the role of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 (PFKFB4) in prostate cancer.

Main Results:

  • Identified PFKFB4 as a critical metabolic node for prostate cancer cell survival.
  • PFKFB4 shunts glucose into the pentose phosphate pathway for NADPH production.
  • Blocking PFKFB4 activity induced reactive oxygen species and subsequent cancer cell death.

Conclusions:

  • PFKFB4 is a vital enzyme for prostate cancer cell metabolism and survival.
  • Targeting PFKFB4 represents a promising therapeutic strategy for prostate cancer treatment.

More Related Videos

Extraction of Aqueous Metabolites from Cultured Adherent Cells for Metabolomic Analysis by Capillary Electrophoresis-Mass Spectrometry11:39

Extraction of Aqueous Metabolites from Cultured Adherent Cells for Metabolomic Analysis by Capillary Electrophoresis-Mass Spectrometry

Published on: June 9, 2019

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...